November 04, 2021 The Details in Biden’s New COVID-19 Vaccine Rules The Biden administration released its COVID-19 vaccine rules covering more than 100 million workers across the U.S., including 17 million employees in health care settings.
November 03, 2021 Report: ‘Alarming’ Increases in Expenses Challenge Nation’s Hospitals The nation’s hospitals are facing a volatile recovery from the pandemic, as escalating labor and supply expenses contribute to narrower overall margins.
November 02, 2021 CDC Panel OKs Pfizer COVID Vaccine for Younger Children The Centers for Disease Control and Prevention’s (CDC) advisory panel recommended the use of the Pfizer-BioNTech COVID-19 vaccine for children between 5 and 11.
November 01, 2021 Four Key Messages for Consumers during Pennie Open Enrollment On Monday, state leaders hosted a press conference at City Hall in Philadelphia to highlight open enrollment for 2022, which began today and continues through January 15, 2022. Consumers have until December 15 to pick a plan that begins New Year’s Day.
October 27, 2021 5 Takeaways from Today’s COVID-19 Briefing The nation’s public health leaders offered encouraging trends in the fight against COVID-19, while urging the remaining 60 million unvaccinated Americans to make an appointment to get vaccinated.
October 22, 2021 Nation’s COVID-19 Booster Plan Takes Shape The U.S. now has booster recommendations for all three available COVID-19 vaccines.
October 15, 2021 FDA Panel Recommends J&J Booster Dose, Reviews Mix-and-Match Approach The U.S. Food and Drug Administration’s (FDA) advisory panel unanimously recommended approving a booster dose of Johnson & Johnson’s COVID-19 vaccine this afternoon.
October 14, 2021 FDA Panel OKs Moderna Booster for High-Risk Groups The U.S. Food and Drug Administration’s (FDA) advisory panel recommended approving a half-dose booster of Moderna’s COVID-19 vaccine for older Americans, health care workers, and other high-risk groups.
October 13, 2021 Legislative Commission Examines Intersection of COVID-19, Diabetes Individuals with diabetes have been among the most critically affected by the COVID-19 pandemic, due both to their increased risk of developing more severe cases of COVID-19 and financial challenges that have increased barriers to treatment.
October 12, 2021 What to Know about First COVID Pill Heading for FDA Review This week, the drug manufacturer Merck applied for emergency approval for its antiviral pill to treat mild-to-moderate COVID-19 in adults at risk of severe cases or hospitalization.